Clinical Trial Update: Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial comparing CAPOX plus Ivonescimab versus CAPOX alone in locally advanced colon cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Ivonescimab (AK112/SMT112)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING